Brought to you by 
Hexal AG acquires remaining 50% of Eon Labs
09 Jan 2001
Executive Summary
Hexal AG, the second-largest generic drug company in Germany, has acquired the 50% of Eon Labs Manufacturing (generics) it didn't already own. Hexal acquired half of the company in 1996.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Partial Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Hexal AG acquires remaining 50% of Eon Labs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice